Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309513 · ClinicalTrials.gov registry record · NA
Evaluation of the Personal Activity Intelligence (PAI) Score
A NA study of Physical Activity, sponsored by Ohio University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT04309513: Completed NA study of Physical Activity, sponsored by Ohio University.
NCT04309513 is a NA study of Physical Activity that has completed, run by Ohio University. The registered enrollment target is 73 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04309513, a NA study of Physical Activity, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a prospective randomized controlled study to evaluate the effectiveness of the Personal Activity Intelligence (PAI) Score to encourage physical activity. Participants will utilize a wearable wrist device that will provide data pertaining to physical activity, to include steps taken, miles walked, heart rate, calories burned, etc. The intervention group devices will also provide a visible PAI score and will be given information about a PAI app they can install on their smart phone to monitor their activity Control participants will be encouraged to work up to at least 10,000 steps a day, higher if possible and reasonable. Those with a device that displays a PAI score (study participants) will be encouraged to work up to and maintain the highest PAI score possible, with 100 being the ideal.
Primary Outcome
Change in Exercise Vital Signs obtained by survey at 2 years. 1. Are you able to walk a mile without significant pain or discomfort? ❒ Yes ❒ No 2. In the past 7 days, how many days did you exercise? \_\_\_\_\_\_ days 3. On days when you exercised, for how long did you exercise (in minutes)? ❒\_\_\_\_\_\_ minutes per day ❒ Does not apply 4. How intense was your typical exercise? * Light (like stretching or slow walking) * Moderate (like brisk walking) * Heavy (like jogging or s
Conditions Studied
Interventions
- BEHAVIORAL PAI score to motivate physical activity
- BEHAVIORAL Step Counter to motivate physical activity
Study Locations (1)
Ohio
- Ohio University - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT04309513 record still lists
NCT04309513 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which PAI score to motivate physical activity is the first listed.
NCT04309513 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04309513 about?
NCT04309513 is a clinical study titled "Evaluation of the Personal Activity Intelligence (PAI) Score". This will be a prospective randomized controlled study to evaluate the effectiveness of the Personal Activity Intelligence (PAI) Score to encourage physical activity. Participants will utilize a wearable wrist device that will provide data pertaining to physical activity, to include steps taken, mi...
What is the current status of trial NCT04309513?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2020-08-01. Estimated completion is 2022-03-01.
What conditions does trial NCT04309513 study?
This clinical trial studies the following conditions: Physical Activity.
What interventions are being tested in trial NCT04309513?
The interventions under investigation include: PAI score to motivate physical activity (BEHAVIORAL), Step Counter to motivate physical activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT04309513?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04309513 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04309513's enrollment target sits among peer trials
73 76th of 131 higher than 56 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI